...your health first  
THERAPEUTIC AREAS  print
Sinuclean Nebules KIT 75

WHAT IT IS.
It is an extremely innovative product fully patented by Galsor, used in the treatment of nose-sinus diseases and their complications (acute rhinosinusitis, chronic purulent rhinosinusitis, nose-sinus polyposis, allergic rhinitis, rinus fungal, otitis media catarrhalis) characterized by: nose-sinus mucosal edema, alteration of the pneumatization of the paranasal sinuses, reduction or loss of ciliary motility and mobility, accumulation of mucopurulent secretions in the nose-sinus compartment and auditory tubes.
COMPOSITION
Sinuclean Nebules 75 contains:
Active ingredients: Cucurbitacins B-D-I-E 75µg extracted from Ecballium Elaterium.
Excipients: Purified water, Eucalyptol, Mint flavor, Methylparahydroxybenzoate, Propylparahydroxybenzoate.
WHEN TO USE
In patients who experience a clinical picture and typical symptoms of upper respiratory tract diseases and of the auditory tubes, which will continue for a period exceeding 10 days, such as: nose-sinus congestion, anterior and/or posterior purulent rhinorrhea, mucopurulent secretions in the auditory tubes, craniofacial pains and/or more intense feeling of heaviness in the morning and marked with the tilt of the head, soft tissue swelling, fever, photophobia, bad breath, reduction or loss of olfactory sensitivity, intellectual torpor, general malaise .

HOW TO USE
Adults (age > 10 years old)
Nebulize in the nostrils the solution obtained by the blending of the two components of the KIT, 1-2 times a day (morning and evening, for 10 consecutive days. The treatment can be repeated after 6-7 days from the first.

To use the solution obtained by blending the two components of the KIT in chronic nose-sinus diseases and post surgery , you should repeat the treatment for at least 2 cycles, interspersed with 6 days of no treatment. In the post-surgery, the product should be administered in the absence of bleeding, usually about 10 days after surgery. The use of the solution obtained by blending the two components of the KIT in the pre-surgery , should be administered for at least 10 consecutive days before surgery. In this case, treatment should be discontinued at least 48 hours before surgery.
The solution obtained by blending the two components of the KIT, is to be administered into the nostrils through aerosol generated by a nebulizer, through a nasal irrigator (i.e Rhinowash) or nasal forks, according to the physician's advice.
HOW IT WORKS
The solution containing Cucurbitacins B-D-I-E, administered in the nostrils through aerosol generated by a nebulizer , through Rhinowash or nasal forks, according to the physician's advice, produce an action on the surface of the epithelium of the mucosa which causes an electrolytic and osmotic alteration, which is followed by a physiological process of evacuation of the mucopurulent secretions from the nose-sinus compartment and the auditory tubes,the restoration of the ciliary mobility and motility, the reduction of the edema of the nose-sinus mucosa, the restoration of the pneumatization of the paranasal sinuses, the reduction of the size of nose-sinus polyps.
WHAT ARE THE EXPECTED BENEFITS
Reduction of edema of the mucosa, restoration of patency of the ostia and consequently of the normal pneumatization of the paranasal sinuses, evacuation of the mucopurulent secretions from the nose-sinus compartment and auditory tubes, restoration of the ciliary mobility and motility, indirect antiseptic effect, disappearance of pain.
WHAT ARE THE ADVANTAGES OVER THE TRADITIONAL THERAPIES
The active ingredients (Cucurbitacins B-D-I-E) are natural biomolecules, without major side effects, which address the root causes of the symptoms of nose-sinus diseases and auditory tubes, do not require long and expensive treatments and, above all, do not show contraindications and/or side effects typical of traditional therapies.
In a multicenter controlled clinical trial, conducted on patients diagnosed with acute, subacute or chronic exacerbation rhinosinusitis, confirmed by CT scan in the group treated with Sinuclean, clinical cure was achieved in 90% of cases, compared with 57% in the group treated only with antibiotics.

 

Promozione Galsor Video Galsor
Master VAS 2015
Miti’ da sfatare e ‘raccomandazioni’ da conoscere
Il Master si articola in Corsi Teorico-Pratici, Letture Magistrali e Tavole Rotonde e ‘Quadra...Read more
GALSOR LANCIA DUE NUOVI PRODOTTI
SINUMER E IPERNASEFLU